The estimated Net Worth of David Ross Smith is at least $20.2 Million dollars as of 3 March 2022. Mr. Smith owns over 8,965 units of Charles River Laboratories International stock worth over $6,733,835 and over the last 9 years he sold CRL stock worth over $9,988,065. In addition, he makes $3,507,300 as Chief Financial Officer and Corporate Executive Vice President at Charles River Laboratories International.
David has made over 35 trades of the Charles River Laboratories International stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 8,965 units of CRL stock worth $1,224,619 on 3 March 2022.
The largest trade he's ever made was exercising 16,817 units of Charles River Laboratories International stock on 2 January 2018 worth over $865,235. On average, David trades about 2,430 units every 30 days since 2015. As of 3 March 2022 he still owns at least 34,784 units of Charles River Laboratories International stock.
You can see the complete history of Mr. Smith stock trades at the bottom of the page.
David Ross Smith serves as Chief Financial Officer, Corporate Executive Vice President of the Company. He has served as our Corporate Executive Vice President and Chief Financial Officer since August 2015. He joined us as Corporate Vice President, Discovery Services through our acquisition of Argenta and BioFocus from Galapagos NV in March 2014 and was promoted to Corporate Senior Vice President, Global Discovery Services, in October 2014. At Galapagos, he served in various capacities, including as Chief Executive Officer of its Galapagos Services division and as Chief Financial Officer. Mr. Smith served as Chief Financial Officer for Cambridge University Hospitals from 2007 to 2013. Mr. Smith spent eight years at PricewaterhouseCoopers prior to joining AstraZeneca in 1997, where he spent the next nine years in various finance and business roles of increasingly greater responsibility.
As the Chief Financial Officer and Corporate Executive Vice President of Charles River Laboratories International, the total compensation of David Smith at Charles River Laboratories International is $3,507,300. There are 1 executives at Charles River Laboratories International getting paid more, with James Foster having the highest compensation of $17,722,100.
David Smith is 54, he's been the Chief Financial Officer and Corporate Executive Vice President of Charles River Laboratories International since 2017. There are 16 older and 5 younger executives at Charles River Laboratories International. The oldest executive at Charles River Laboratories International Inc. is Stephen Chubb, 76, who is the Independent Director.
Over the last 22 years, insiders at Charles River Laboratories International have traded over $220,588,205 worth of Charles River Laboratories International stock and bought 18,392 units worth $3,841,397 . The most active insiders traders include James C Foster, Richard F Wallman, and David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of $2,223,188. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth $354,861.
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Charles River Laboratories International executives and other stock owners filed with the SEC include: